1733 related articles for article (PubMed ID: 9723960)
21. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats.
Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Cervenka L; Majid DS
J Hypertens; 2007 Nov; 25(11):2257-65. PubMed ID: 17921820
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.
Sigusch HH; Campbell SE; Weber KT
Cardiovasc Res; 1996 Apr; 31(4):546-54. PubMed ID: 8689646
[TBL] [Abstract][Full Text] [Related]
23. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
24. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
[TBL] [Abstract][Full Text] [Related]
25. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
[TBL] [Abstract][Full Text] [Related]
26. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats.
Rivera-Jardón FF; Castro-Moreno P; Figueroa-Guillén ES; Gallardo-Ortíz IA; Godínez-Hernández D; Ibarra-Barajas M
Proc West Pharmacol Soc; 2009; 52():47-9. PubMed ID: 22128421
[TBL] [Abstract][Full Text] [Related]
28. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation.
Criado M; Flores O; Hidalgo F; López-Novoa JM; Sánchez-Rodríguez A
Can J Physiol Pharmacol; 1999 Feb; 77(2):111-7. PubMed ID: 10535701
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
[TBL] [Abstract][Full Text] [Related]
30. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase.
Kiss A; Jurkovicova D; Jezova D; Krizanova O
Endocr Regul; 2001 Jun; 35(2):65-70. PubMed ID: 11563933
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of L-NOARG and L-NAME on basal blood flow and ACh-induced vasodilatation in rat diaphragmatic microcirculation.
Chang HY; Chen CW; Hsiue TR
Br J Pharmacol; 1997 Jan; 120(2):326-32. PubMed ID: 9117127
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II natriuresis and anti-natriuresis: role of renal artery pressure in anaesthetized dogs.
Olsen ME; Hall JE; Montaini JP; Guyton AC
J Hypertens Suppl; 1984 Dec; 2(3):S347-50. PubMed ID: 6599679
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
[TBL] [Abstract][Full Text] [Related]
34. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
35. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
Pucci ML; Lin L; Nasjletti A
J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the renal effects of contrast media by endothelium-derived nitric oxide in the rat.
Touati C; Idee JM; Deray G; Santus R; Balut C; Beaufils H; Jouanneau C; Bourbouze R; Doucet D; Bonnemain B
Invest Radiol; 1993 Sep; 28(9):814-20. PubMed ID: 8225887
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products.
Sigusch HH; Ou R; Katwa LC; Campbell SE; Ganjam VK; Reddy HK; Weber KT
Cardiovasc Res; 1995 Aug; 30(2):291-8. PubMed ID: 7585817
[TBL] [Abstract][Full Text] [Related]
38. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins.
Olsen ME; Hall JE; Montani JP; Cornell JE
J Hypertens Suppl; 1985 Dec; 3(3):S255-8. PubMed ID: 2856712
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
Handa RK; Strandhoy JW
J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
[TBL] [Abstract][Full Text] [Related]
40. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
